Charman S - Search Results

1

Investigating outcome measures for assessing airway clearance techniques in adults with cystic fibrosis: protocol of a single-centre randomised controlled crossover trial.

Stanford G, Davies JC, Usmani O, Banya W, Charman S, Jones M, Simmonds NJ, Bilton D. Stanford G, et al. Among authors: charman s. BMJ Open Respir Res. 2020 Oct;7(1):e000694. doi: 10.1136/bmjresp-2020-000694. BMJ Open Respir Res. 2020. PMID: 33020113 Free PMC article.

2

Clinimetric analysis of outcome measures for airway clearance in people with cystic fibrosis: a systematic review.

Stanford GE, Jones M, Charman SC, Bilton D, Usmani OS, Davies JC, Simmonds NJ. Stanford GE, et al. Among authors: charman sc. Ther Adv Respir Dis. 2022 Jan-Dec;16:17534666221122572. doi: 10.1177/17534666221122572. Ther Adv Respir Dis. 2022. PMID: 36066081 Free PMC article.

3

Long-term safety study of colistimethate sodium (Colobreathe®): Findings from the UK Cystic Fibrosis Registry.

Kaplan S, Lee A, Caine N, Charman SC, Bilton D. Kaplan S, et al. Among authors: charman sc. J Cyst Fibros. 2021 Mar;20(2):324-329. doi: 10.1016/j.jcf.2020.08.001. Epub 2020 Aug 14. J Cyst Fibros. 2021. PMID: 32807645 Free article.

4

Disease progression in patients with cystic fibrosis treated with ivacaftor: Data from national US and UK registries.

Volkova N, Moy K, Evans J, Campbell D, Tian S, Simard C, Higgins M, Konstan MW, Sawicki GS, Elbert A, Charman SC, Marshall BC, Bilton D. Volkova N, et al. Among authors: charman sc. J Cyst Fibros. 2020 Jan;19(1):68-79. doi: 10.1016/j.jcf.2019.05.015. Epub 2019 Jun 10. J Cyst Fibros. 2020. PMID: 31196670 Free article.

5

Factors associated with clinical progression to severe COVID-19 in people with cystic fibrosis: A global observational study.

Carr SB, McClenaghan E, Elbert A, Faro A, Cosgriff R, Abdrakhmanov O, Brownlee K, Burgel PR, Byrnes CA, Cheng SY, Colombo C, Corvol H, Daneau G, Goss CH, Gulmans V, Gutierrez H, Harutyunyan S, Helmick M, Jung A, Kashirskaya N, McKone E, Melo J, Middleton PG, Mondejar-Lopez P, de Monestrol I, Nährlich L, Padoan R, Parker M, Pastor-Vivero MD, Rizvi S, Ruseckaite R, Salvatore M, da Silva-Filho LVRF, Versmessen N, Zampoli M, Marshall BC, Stephenson AL; CF Registry Global Collaboration. Carr SB, et al. J Cyst Fibros. 2022 Jul;21(4):e221-e231. doi: 10.1016/j.jcf.2022.06.006. Epub 2022 Jun 13. J Cyst Fibros. 2022. PMID: 35753987 Free PMC article.

6

Who are the 10%? - Non eligibility of cystic fibrosis (CF) patients for highly effective modulator therapies.

Desai M, Hine C, Whitehouse JL, Brownlee K, Charman SC, Nagakumar P. Desai M, et al. Respir Med. 2022 Aug;199:106878. doi: 10.1016/j.rmed.2022.106878. Epub 2022 May 16. Respir Med. 2022. PMID: 35633605

7

Lung function in children with cystic fibrosis in the USA and UK: a comparative longitudinal analysis of national registry data.

Schlüter DK, Ostrenga JS, Carr SB, Fink AK, Faro A, Szczesniak RD, Keogh RH, Charman SC, Marshall BC, Goss CH, Taylor-Robinson D. Schlüter DK, et al. Among authors: charman sc. Thorax. 2022 Feb;77(2):136-142. doi: 10.1136/thoraxjnl-2021-216849. Epub 2021 May 11. Thorax. 2022. PMID: 33975926 Free PMC article.

8

Ivacaftor Is Associated with Reduced Lung Infection by Key Cystic Fibrosis Pathogens. A Cohort Study Using National Registry Data.

Frost FJ, Nazareth DS, Charman SC, Winstanley C, Walshaw MJ. Frost FJ, et al. Among authors: charman sc. Ann Am Thorac Soc. 2019 Nov;16(11):1375-1382. doi: 10.1513/AnnalsATS.201902-122OC. Ann Am Thorac Soc. 2019. PMID: 31319678

9

Prostate Imaging Compared to Transperineal Ultrasound-guided biopsy for significant prostate cancer Risk Evaluation (PICTURE): a prospective cohort validating study assessing Prostate HistoScanning.

Simmons LAM, Kanthabalan A, Arya M, Briggs T, Charman SC, Freeman A, Gelister J, Jameson C, McCartan N, Moore CM, van der Muelen J, Emberton M, Ahmed HU. Simmons LAM, et al. Prostate Cancer Prostatic Dis. 2019 May;22(2):261-267. doi: 10.1038/s41391-018-0094-1. Epub 2018 Oct 2. Prostate Cancer Prostatic Dis. 2019. PMID: 30279583

10

Is the Venner-PneuX Endotracheal Tube System a Cost-Effective Option for Post Cardiac Surgery Care?

Andronis L, Oppong RA, Manga N, Senanayake E, Gopal S, Charman S, Giri R, Luckraz H. Andronis L, et al. Among authors: charman s. Ann Thorac Surg. 2018 Sep;106(3):757-763. doi: 10.1016/j.athoracsur.2018.03.058. Epub 2018 Apr 27. Ann Thorac Surg. 2018. PMID: 29709502

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

327 results

Search Page